Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Evolus Inc shares valued at $33,397 were sold by Avelar Rui on May 12 ’25. At $9.87 per share, Avelar Rui sold 3,385 shares. The insider’s holdings dropped to 359,082 shares worth approximately $3.35 million following the completion of this transaction.
Also, Beaver Sandra sold 6,494 shares, netting a total of over 65,070 in proceeds. Following the sale of shares at $10.02 each, the insider now holds 167,089 shares.
Before that, MOATAZEDI DAVID had sold 15,787 shares from its account. In a trade valued at $155,756, the insider traded Evolus Inc shares for $9.87 each. Upon closing the transaction, the insider’s holdings decreased to 15,787 shares, worth approximately $4.6 million.
As published in their initiating research note from BTIG Research on April 17, 2025, Evolus Inc [EOLS] has been a Buy and the price target has been revised to $21. Analysts at Barclays upgraded the stock from ‘”an Equal weight”‘ to ‘”an Overweight”‘ outlook in a report released in late January. As of June 23, 2022, Needham has initiated its “Buy” rating for EOLS. Earlier on May 12, 2022, Barclays upgraded its rating. Their new recommendation was “an Equal weight” for EOLS stock which previously was a “an Underweight”.
Analyzing EOLS Stock Performance
During the last five days, there has been a drop of approximately -2.61%. Over the course of the year, Evolus Inc shares have dropped approximately -15.40%. Shares of the company reached a 52-week high of $17.12 on 02/13/25 and a 52-week low of $8.67 on 04/09/25.
Support And Resistance Levels for Evolus Inc (EOLS)
According to the 24-hour chart, there is a support level at 9.09, which, if violated, would cause prices to drop to 8.85. In the upper region, resistance lies at 9.49. The next price resistance is at 9.65. RSI (Relative Strength Index) is 36.15 on the 14-day chart, showing neutral technical sentiment.
